Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 54, Issue 3

Issues

Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma

Gunnar Schalasta / Anna Börner / Andrea Speicher / Martin Enders
Published Online: 2015-08-18 | DOI: https://doi.org/10.1515/cclm-2015-0522

Abstract

Background: Quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma has become the standard of care in the management of HIV-infected patients. There are several commercially available assays that have been implemented for the detection of HIV-1 RNA in plasma. Here, the new Hologic Aptima® HIV-1 Quant Dx assay (Aptima HIV) was compared to the Roche COBAS® TaqMan® HIV-1 Test v2.0 for use with the High Pure System (HPS/CTM).

Methods: The performance characteristics of the assays were assessed using commercially available HIV reference panels, dilution of the WHO 3rd International HIV-1 RNA International Standard (WHO-IS) and plasma from clinical specimens. Assay performance was determined by linear regression, Deming correlation analysis and Bland-Altman analysis.

Results: Testing of HIV-1 reference panels revealed excellent agreement. The 61 clinical specimens quantified in both assays were linearly associated and strongly correlated.

Conclusions: The Aptima HIV assay offers performance comparable to that of the HPS/CTM assay and, as it is run on a fully automated platform, a significantly improved workflow.

Keywords: Aptima; COBAS; HIV; quantification; TMA; viral load

References

  • 1.

    Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997;126:929–38.Google Scholar

  • 2.

    Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946–54.Google Scholar

  • 3.

    O’Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med 1997;126:939–45.Google Scholar

  • 4.

    Asboe D, Aitken C, Boffito M, Booth C, Cane P, Fakoya A, et al., on behalf of the BHIVA Guidelines Subcommittee. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med 2012;13:1–44.CrossrefGoogle Scholar

  • 5.

    Website: Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available from: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 1 December, 2014.

  • 6.

    Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. J Am Med Assoc 2012;308:387–402.Google Scholar

  • 7.

    World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: WHO Press, 2013.Google Scholar

  • 8.

    Bourlet T, Signori-Schmuck A, Roche L, Icard V, Saoudin H, Trabaud MA, et al. HIV-1 load comparison using four commercial real-time assays. J Clin Microbiol 2011;49:292–7.Web of ScienceCrossrefGoogle Scholar

  • 9.

    Church D, Gregson D, Lloyd T, Klein M, Beckthold B, Laupland K, et al. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2 and Versant assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol 2011;49:118–24.Web of ScienceGoogle Scholar

  • 10.

    Garcia-Diaz A, Clewley GS, Booth CL, Labett W, McAllister N, Geretti AM. Comparative evaluation of the performance of the Abbott Real-Time Human Immunodeficiency Virus type 1 (HIV-1) assay for the measurement of HIV-1 plasma viral load following automated specimen preparation. J Clin Microbiol 2006;44:1788–91.CrossrefGoogle Scholar

  • 11.

    Garcia-Diaz A, Labbett W, Clewley GS, Guerrero-Ramos A, Geretti AM. Comparative evaluation of the Artus HIV-1 QS-RGQ assay and the Abbott RealTime HIV-1 assay for the quantification of HIV-1 RNA in plasma. J Clin Virol 2013;57:66–9.Web of ScienceGoogle Scholar

  • 12.

    Schutten M, Peters D, Back NK, Beld M, Beuselinck K, Foulongne V, et al. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2007;45: 1712–7.Web of ScienceCrossrefGoogle Scholar

  • 13.

    Perrin L, Pawlotsky JM, Bouvier-Alias M, Sarrazin C, Zeuzem S, Colucci G. Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J Clin Microbiol 2006;44:4371–5.CrossrefGoogle Scholar

  • 14.

    Coombs R, Bremer J, Sanchez J, La Rosa A, Fernandes H, Ganoza C, et al. Clinical performance evaluation of the COBAS TaqMan HIV-1 Test for use with the High Pure System v2.0 (HPS/CTM HIV v2) using manual specimen extraction, compared to the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0 (CAP/CTM HIV Test v2) using automated specimen extraction. J Int AIDS Soc 2012;15(Suppl 3):THPE060.Google Scholar

  • 15.

    Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Goncales FL Jr, et al. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J Hepatol 2005;43:425–33.CrossrefGoogle Scholar

  • 16.

    Wiesmann F, Naeth G, Sarrazin C, Berger A, Kaiser R, Ehret R, et al. Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors. Med Microbiol Immunol 2015;204:515–25.Web of ScienceGoogle Scholar

  • 17.

    Pyne MT, Vest L, Clement J, Lee J, Rosvall JR, Luk K, et al. Comparison of three Roche hepatitis B virus viral load assay formats. J Clin Microbiol 2012;50:2337–42.CrossrefWeb of ScienceGoogle Scholar

  • 18.

    Hill CS. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev Mol Diagn 2001;1:445–55.CrossrefGoogle Scholar

  • 19.

    Janssens W, Heyndrickx L, Fransen K, Motte J, Peeters M, Nkengasong JN, et al. Genetic and phylogenetic analysis of env subtypes G and H in central Africa. Aids Res Hum Retroviruses 1994;10:877–9.Google Scholar

  • 20.

    Paba P, Fabeni L, Ciccozzi M, Perno CF, Ciotti M. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study. J Virol Methods 2011;173:399–402.Web of ScienceGoogle Scholar

  • 21.

    Ruelle J, Debaisieux L, Vancutsem E, De Bel A, Delforge ML, Piérard D, et al. HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability. BMC Infect Dis 2012;12:100–5.CrossrefWeb of ScienceGoogle Scholar

  • 22.

    Yan CS, Hanafi I, Kelleher AD, Carr AD, Amin J, McNally LP, et al. Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. J Clin Virol 2010;49:249–53.Web of ScienceCrossrefGoogle Scholar

About the article

Corresponding author: Gunnar Schalasta, Prof. Gisela Enders and Kollegen MVZ Rosenbergstr. 85, 70193 Stuttgart, Germany, Phone: +49 7116357140, E-mail:


Received: 2015-06-05

Accepted: 2015-07-22

Published Online: 2015-08-18

Published in Print: 2016-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 54, Issue 3, Pages 493–499, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2015-0522.

Export Citation

©2016 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Clara A. Agutu, Caroline J. Ngetsa, Matt A. Price, Tobias F. Rinke de Wit, Gloria Omosa-Manyonyi, Eduard J. Sanders, Susan M. Graham, and Kwasi Torpey
PLOS ONE, 2019, Volume 14, Number 6, Page e0218369
[2]
Frank Wiesmann, Robert Ehret, Gudrun Naeth, Martin Däumer, Jörg Fuhrmann, Rolf Kaiser, Christian Noah, Martin Obermeier, Gunnar Schalasta, Carsten Tiemann, Eva Wolf, Heribert Knechten, Patrick Braun, and Angela M. Caliendo
Journal of Clinical Microbiology, 2018, Volume 56, Number 10
[3]
Christina Yek, Marta Massanella, Tashi Peling, Kristen Lednovich, Sangeetha V. Nair, Andrew Worlock, Milenka Vargas, Sara Gianella, Ronald J. Ellis, Matthew C. Strain, Michael P. Busch, C. Thomas Nugent, Douglas D. Richman, and Angela M. Caliendo
Journal of Clinical Microbiology, 2017, Volume 55, Number 8, Page 2544
[4]
Soya S. Sam, Jaclynn R. Kurpewski, Susan Cu-Uvin, Angela M. Caliendo, and A. J. McAdam
Journal of Clinical Microbiology, 2016, Volume 54, Number 4, Page 1036
[5]
Mark M. Manak, Holly R. Hack, Sangeetha V. Nair, Andrew Worlock, Jennifer A. Malia, Sheila A. Peel, Linda L. Jagodzinski, and A. M. Caliendo
Journal of Clinical Microbiology, 2016, Volume 54, Number 10, Page 2575
[6]
Serena Longo, Isabella Bon, Giuseppina Musumeci, Alessia Bertoldi, Vanessa D'Urbano, Leonardo Calza, and Maria Carla Re
Health Science Reports, 2018, Page e31
[7]
Angelos. Hatzakis, Helen Papachristou, Sangeetha J. Nair, Jacqueline Fortunko, Tracy Foote, HeeCheol Kim, Tashi L. Peling, and Andrew J. Worlock
Virology Journal, 2016, Volume 13, Number 1
[8]
K. Sauné, S. Raymond, J. Boineau, C. Pasquier, and J. Izopet
Journal of Clinical Virology, 2016, Volume 84, Page 70

Comments (0)

Please log in or register to comment.
Log in